driver of pathological process following TBI. The studies have reported that the neuro-inflammation after TBI is because of activation of cAMP-PKA inflammatory signalling pathways in neuronal cells damaging
driver mutations than on the specific sets of mutated genes. The reduced sets of predicted functional mutations can significantly facilitate determining genomic markers of outcome, identifying the activated pathways
phosphorylation of N-terminus of EGFR and activation of EGFR signaling pathway. Expression of MAN2A1-FER generated dramatic increase of growth and invasion of cancers, while removal of MAN2A1 ... Taken together, we…
most frequent cause of in-hospital infections in Portugal and a major driver for resource utilization. Vancomycin and Linezolid are widely used in ABSSSI but have been associated with ... MRSA infected population when…
PDAC) is known as cancer with very poor prognosis. KRAS oncogene is a major driver of PDAC tumorigenesis but its role as prognostic or predictive factor is not clear ... present study was to investigate the prognostic…
phosphoproteins, interacting proteins and target genes expression, 36 hub nodes including known breast cancer drivers, such as TP53, MYC and BRCA1, were identified in PRKD2 and PRKD3 regulating networks. ELAVL1 ... were…
circuitry of DLBCL reveals a diverse range of somatic mutations and aberrant intracellular signaling pathways that characterize distinct molecular subsets. The next major breakthrough in DLBCL therapy during this…
disease, and multiple sclerosis. Advances in understanding the immune cells involved, the molecular pathways driving neuroinflammation, and the potential for immune-modulating therapies are discussed. The findings…
Glioblastoma stem cells (GSCs) have been proposed as central drivers of tumor progression, treatment resistance and tumor recurrence. Although several molecular markers, such as Wnt, Hedgehog, Notch ... downregulation…
events may also influence the viability and clinical behavior of a given tumor. Some driver mutations are found to be targets for therapy, whereas others play crucial roles in resistance ... that tumor cells have a very…
Drug resistance (DR) is a main driver of post-chemotherapy recurrence and metastasis and therefore a challenging hindrance to tumor therapy. Several mechanisms including increased drug efflux and drug detoxification…
transfer, and the two plasmon decay instability. StarDriver offers potentially superior flexibility in laser drivers for ICF, enabling almost arbitrary sequencing of wavelength, polarization, focus, and fine control…
transfer, and the two plasmon decay instability. StarDriver offers potentially superior flexibility in laser drivers for ICF, enabling almost arbitrary sequencing of wavelength, polarization, focus, and fine control…
characterized by aberrant lipid metabolism, amino acids metabolism, mitochondrial biogenesis, and other bioenergetics metabolic pathways. However, the two noticeable characteristics of tumor cell metabolism are the…
proliferative or apoptotic signaling processes. The data revealed protein clusters involved in various signaling pathways, providing a preliminary vista of the cause-effect relationships that confer cancer cells a…
being metabolically active such that it gets shunted through the arachidonic acid pathways, creating antiinflammatory products responsible for upregulating genes of synaptic proteins, phosphatides, and receptors. In…
estimation of BC aggressiveness and b) use of agents which specifically target oncogenic driver-molecules. Those new approaches were made possible by important advances in cancer biopathology. Molecular classification…
with over 600,000 cases annually worldwide. Cirrhosis of the liver is a major driver in the pathogenesis of HCC in addition to direct proliferative stimuli from hepatitis viruses. Liver ... stimulates in the liver…
launches in Europe were the departure point for the fast moving industry. The early pathway in the development of biosimilars was based on advances in protein characterization with the ability ... science of…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.